cardiovascular disease therapeutic (Lexicon/Abgenix)

N/A

Report date: 2025/03/17 20:00:36

Base Information

Drug Namecardiovascular disease therapeutic (Lexicon/Abgenix)
Drug Alias NameLG101 inhibitors (Lexicon/Abgenix)atherosclerosis therapeutic (Abgenix/Lexicon)LG914 inhibitors (Lexicon/Abgenix)thrombosis therapeutic (Lexicon/Abgenix)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosisCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLexicon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbgenix IncorporatedLexicon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAtherosclerosisCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksN/A